Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.
about
Mechanisms of Hippo pathway regulationMesenchymal tumours of the mediastinum--part IIA Review: Molecular Aberrations within Hippo Signaling in Bone and Soft-Tissue SarcomasNovel uses of immunohistochemistry in the diagnosis and classification of soft tissue tumorsA rare case of intravascular epithelioid hemangioendothelioma of the cephalic vein treated with surgery and postoperative radiation therapy: a case report and review of the literatureHippo Pathway in Organ Size Control, Tissue Homeostasis, and CancerMolecular pathology of bone tumours: diagnostic implications.Epithelioid Hemangioendothelioma: clinicopathologic, immunhistochemical, and molecular genetic analysis of 39 cases.ZFP36-FOSB fusion defines a subset of epithelioid hemangioma with atypical featuresAdhesion molecule-mediated hippo pathway modulates hemangioendothelioma cell behaviorMalignant vascular tumors--an update.Sarcoma classification: an update based on the 2013 World Health Organization Classification of Tumors of Soft Tissue and Bone.Thoracic epithelioid malignant vascular tumors: a clinicopathologic study of 52 cases with emphasis on pathologic grading and molecular studies of WWTR1-CAMTA1 fusions.Myoepithelial neoplasms of soft tissue: an updated review of the clinicopathologic, immunophenotypic, and genetic featuresBCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children.Disease implications of the Hippo/YAP pathway.Epithelioid hemangioendothelioma: an overview and update on a rare vascular tumorTMED6-COG8 is a novel molecular marker of TFE3 translocation renal cell carcinoma.Frequent FOS Gene Rearrangements in Epithelioid Hemangioma: A Molecular Study of 58 Cases With Morphologic Reappraisal.Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.Epithelioid Hemangioendothelioma of the Maxillary Sinus.Epithelioid hemangioendotheliomas with TFE3 gene translocations are compossible with CAMTA1 gene rearrangements.Diagnostic utility of FOSB immunohistochemistry in pseudomyogenic hemangioendothelioma and its histological mimics.TFE3 translocation-associated perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: morphology, immunophenotype, differential diagnosis.Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoproteinLong term follow up after resection emphasizes the role of surgery in Primary Hepatic Epithelioid Hemangioendothelioma.Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themesIdentification of molecular tumor markers in renal cell carcinomas with TFE3 protein expression by RNA sequencing.Histone demethylase JMJD1C regulates esophageal cancer proliferation Via YAP1 signaling.Evolving techniques for gene fusion detection in soft tissue tumours.The role of cytogenetics and molecular diagnostics in the diagnosis of soft-tissue tumors.Recently characterized soft tissue tumors that bring biologic insight.Molecular diagnosis of soft tissue neoplasia: clinical applications and recent advances.The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.Molecular diagnostics in soft tissue sarcomas and gastrointestinal stromal tumors.Updates in the approach to intrathoracic sarcomas.Lung cancer: developments, concepts, and specific aspects of the new WHO classification.Histology-Driven Therapy: The Importance of Diagnostic Accuracy in Guiding Systemic Therapy of Soft Tissue Tumors.Massive parallel sequencing in sarcoma pathobiology: state of the art and perspectives.Advances in the clinicopathological and molecular classification of cutaneous mesenchymal neoplasms.
P2860
Q26771285-98338B8E-8678-4E17-915A-6410710FBC29Q26781697-1ABA7DC1-6079-481D-9D04-1E349A3D7A20Q26782842-E22CEFBD-2F7D-4922-A085-72A9F5C88E97Q27001114-84B540FE-97AA-4D9B-8316-A80B553D3368Q27692297-1210F115-9F44-4E4F-8720-BB371298228AQ28269498-363B3141-A86C-4154-9C81-FFD063D35254Q33275105-15F409DB-23D3-40B4-BA62-C96172C328C4Q33907259-8FA41801-38A9-4F2A-8902-41B4186C281CQ34501081-CDDA0E4E-8427-466E-83C8-95AD2B86930EQ34592780-F7EF6C7A-0F0E-44D2-9639-421D9F34319DQ34658662-61ABEF17-12F5-4E18-9E05-192E91CC4F9CQ34660467-77FC7D7A-3F42-4C5C-8418-E0D02C8CE0B7Q34716216-5683C25F-2A08-4622-AC26-95B9C5DD9F97Q35243923-2EAFC911-91C8-449A-8C53-2BBA1734C988Q35268915-FCFFB054-8C6C-4011-A704-F37D280D91EDQ35269102-BAF20308-297C-4475-8B52-24093268D43CQ35569416-925AA77F-2CB1-440C-9D96-40A22E7BA53BQ35632133-E2979282-CC52-47C1-8B31-992F6981B6CFQ36054323-AFDA8842-799D-4787-9B41-447C0802A4FBQ36803294-0EF9B810-5829-4DB7-935A-ECF5C21BD4ECQ36819967-526D5414-8AC0-49BD-AE54-8315A357FE46Q36946548-AEF9C1D0-CA6E-4F1F-8694-B6511CD4A7C1Q37169734-5C26FFE2-A20C-48BD-AE46-7E573EF3F63BQ37170478-36D234E5-CD10-4081-884C-EC225C896892Q37172322-9890A48A-98E5-42E0-8E16-200D21E0CFE4Q37198746-CC2228F2-7E3B-4D81-977E-F05394C19E03Q37234080-3DD371C3-D3ED-419B-9A11-727370778344Q37384169-69272F83-583A-4A5E-80BF-AD2CBCBC4CCCQ37596831-29DCAD78-D42F-40B1-BD09-689E0431D204Q38169792-C5A152E3-FA8E-48B5-8D7C-B217E69F647CQ38175313-19FBAE4E-C46C-4E72-AF25-742F406C3147Q38175314-A4EF0F95-89C2-443D-B0DE-86E41AB498C8Q38238574-F8A9D9BA-EC39-47D9-96F7-204AEA4438CDQ38255378-D2CEF88F-3C84-4846-A1C9-9C38AFE33937Q38378763-7CD6576B-A91A-4DF1-B908-0CB650577AF4Q38541487-2370EDBF-ED6E-48A1-BD4B-6D1FA32677DBQ38551599-1D3B04F6-1A08-42DE-9AC4-A36474B8A770Q38591828-697A824E-EB70-47D5-8E49-B97F32604BDFQ38625070-37211E72-3132-4650-99B8-0E5248ED7B24Q38695749-E6EB7000-8EB9-4E57-BE70-25E89764C461
P2860
Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.
@ast
Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.
@en
type
label
Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.
@ast
Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.
@en
prefLabel
Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.
@ast
Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.
@en
P2093
P2860
P50
P356
P1476
Novel YAP1-TFE3 fusion defines a distinct subset of epithelioid hemangioendothelioma.
@en
P2093
Christopher D M Fletcher
Chun-Liang Chen
Cristina R Antonescu
Francois Le Loarer
Hsiao-Wei Chen
Ilan Weinreb
Juan-Miguel Mosquera
Meera Hameed
Nursat Pathan
P2860
P304
P356
10.1002/GCC.22073
P577
2013-06-05T00:00:00Z